2. Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 2006;19:389-394.
3. Lucas AR, Melton LJ 3rd, Crowson CS, et al. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc 1999;74:972-977.
4. Schorr M, Thomas JJ, Eddy KT, et al. Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5. Int J Eat Disord 2017;50:343-351.
6. Soyka LA, Grinspoon S, Levitsky LL, et al. The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999;84:4489-4496.
7. Grinspoon S, Baum H, Lee K, et al. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3864-3870.
8. Hotta M, Shibasaki T, Sato K, et al. The importance of body weight history in the occurrence and recovery of osteoporosis in patients with anorexia nervosa: evaluation by dual X-ray absorptiometry and bone metabolic markers. Eur J Endocrinol 1998;139:276-283.
9. Idolazzi L, El Ghoch M, Dalle Grave R, et al. Bone metabolism in patients with anorexia nervosa and amenorrhoea. Eat Weight Disord 2018;23:255-261.
11. Miller KK, Grinspoon S, Gleysteen S, et al. Preservation of neuroendocrine control of reproductive function despite severe undernutrition. J Clin Endocrinol Metab 2004;89:4434-4438.
13. Lawson EA, Miller KK, Bredella MA, et al. Hormone predictors of abnormal bone microarchitecture in women with anorexia nervosa. Bone 2010;46:458-463.
14. Rigotti NA, Nussbaum SR, Herzog DB, et al. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984;311:1601-1606.
17. Golden NH, Jacobson MS, Schebendach J, et al. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997;151:16-21.
18. Solmi M, Veronese N, Correll CU, et al. Bone mineral density, osteoporosis, and fractures among people with eating disorders: a systematic review and meta-analysis. Acta Psychiatr Scand 2016;133:341-351.
19. do Carmo I, Mascarenhas M, Macedo A, et al. A study of bone density change in patients with anorexia nervosa. Eur Eat Disord Rev 2007;15:457-462.
20. Kanbur NÖ, Derman O, Kinik E. The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescents. J Bone Miner Metab 2005;23:76-83.
22. Tomova A, Kumanov P. Sex differences and similarities of hormonal alterations in patients with anorexia nervosa. Andrologia 1999;31:143-147.
23. Clarke BL, Khosla S. Androgens and bone. Steroids 2009;74:296-305.
24. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5™. 5th ed. Arlington, VA: American Psychiatric Publishing, Inc.; 2013.
29. Halvorsen I, Platou D, Hoiseth A. Bone mass eight years after treatment for adolescent-onset anorexia nervosa. Eur Eat Disord Rev 2012;20:386-392.
33. Böker J, Völzke H, Nauck M, et al. Associations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 with bone quality in the general adult population. Clin Endocrinol (Oxf) 2018;88:830-837.
34. Counts DR, Gwirtsman H, Carlsson LM, et al. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 1992;75:762-767.
35. Trombetti A, Richert L, Herrmann FR, et al. Selective determinants of low bone mineral mass in adult women with anorexia nervosa. Int J Endocrinol 2013;2013:897193.
37. Grinspoon S, Miller K, Coyle C, et al. Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 1999;84:2049-2055.
39. Kaye WH. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res 1996;62:65-74.
40. Maguire S, O'Dell A, Touyz L, et al. Oxytocin and anorexia nervosa: a review of the emerging literature. Eur Eat Disord Rev 2013;21:475-478.
41. Schorr M, Marengi DA, Pulumo RL, et al. Oxytocin and its relationship to body composition, bone mineral density, and hip geometry across the weight spectrum. J Clin Endocrinol Metab 2017;102:2814-2824.
43. Howe TE, Shea B, Dawson LJ, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev 2011;Cd000333.
44. Waugh EJ, Woodside DB, Beaton DE, et al. Effects of exercise on bone mass in young women with anorexia nervosa. Med Sci Sports Exerc 2011;43:755-763.
46. Kooh SW, Noriega E, Leslie K, et al. Bone mass and soft tissue composition in adolescents with anorexia nervosa. Bone 1996;19:181-188.
47. Caillot-Augusseau A, Lafage-Proust MH, Margaillan P, et al. Weight gain reverses bone turnover and restores circadian variation of bone resorption in anorexic patients. Clin Endocrinol (Oxf) 2000;52:113-121.
48. Jagielska G, Wolańczyk T, Komender J, et al. Bone mineral content and bone mineral density in adolescent girls with anorexia nervosa--a longitudinal study. Acta Psychiatr Scand 2001;104:131-137.
49. Soyka LA, Misra M, Frenchman A, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2002;87:4177-4185.
50. Castro J, Toro J, Lazaro L, et al. Bone mineral density in male adolescents with anorexia nervosa. J Am Acad Child Adolesc Psychiatry 2002;41:613-618.
51. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005;90:3179-3185.
54. Stone M, Briody J, Kohn MR, et al. Bone changes in adolescent girls with anorexia nervosa. J Adolesc Health 2006;39:835-841.
56. Misra M, Prabhakaran R, Miller KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab 2008;93:1231-1237.
59. Seeman E, Szmukler GI, Formica C, et al. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res 1992;7:1467-1474.
61. Muñoz MT, Morandé G, García-Centenera JA, et al. The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa. Eur J Endocrinol 2002;146:45-50.
62. Strokosch GR, Friedman AJ, Wu SC, et al. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. J Adolesc Health 2006;39:819-827.
63. Golden NH, Lanzkowsky L, Schebendach J, et al. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol 2002;15:135-143.
64. Misra M, Katzman D, Miller KK, et al. Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa. J Bone Miner Res 2011;26:2430-2438.
65. Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab 2005;90:1428-1433.
67. Bloch M, Ish-Shalom S, Greenman Y, et al. Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study. Psychiatry Res 2012;200:544-549.
68. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab 2002;87:4935-4941.
70. DiVasta AD, Feldman HA, Beck TJ, et al. Does hormone replacement normalize bone geometry in adolescents with anorexia nervosa? J Bone Miner Res 2014;29:151-157.
71. Miller KK, Grieco KA, Mulder J, et al. Effects of risedronate on bone density in anorexia nervosa. J Clin Endocrinol Metab 2004;89:3903-3906.
72. Jamieson A, Pelosi AJ. Use of denosumab in a patient with chronic anorexia nervosa and osteoporosis. Am J Med 2016;129:e47.
73. Isobe F, Nakamura Y, Suzuki T, et al. Effects of denosumab on osteoporosis in three cases with anorexia nervosa and a review of the literature. Mod Rheumatol Case Rep 2018;2:104-106.
77. Grinspoon S, Thomas L, Miller K, et al. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab 2002;87:2883-2891.
79. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004;351:987-997.
80. Sienkiewicz E, Magkos F, Aronis KN, et al. Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women. Metabolism 2011;60:1211-1221.
81. Iwamoto J. Vitamin K(2) therapy for postmenopausal osteoporosis. Nutrients 2014;6:1971-1980.
82. Iketani T, Kiriike N, Murray , et al. Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res 2003;117:259-269.
84. Rosen CJ, Hochberg MC, Bonnick SL, et al. Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res 2005;20:141-151.